Rchr
J-GLOBAL ID：201801006187158350   Update date: Jan. 30, 2024

Tokuda Emi

トクダ エミ | Tokuda Emi
Affiliation and department：
Fukushima Medical University School of Medicine (Clinical Medicin) Department of Medical Oncology

About Fukushima Medical University School of Medicine (Clinical Medicin) Department of Medical Oncology


Job title： Associate Professor
Homepage URL  (1)： https://www.juntendo.ac.jp/graduate/kenkyudb/search/researcher.php?MID=4944
Research field  (3)： Tumor biology ,  Tumor diagnostics and therapeutics ,  General surgery, pediatric surgery
Research keywords  (2)： Transrational research ,  Breast cancer
Research theme for competitive and other funds  (4)：
  • 2021 - 2024 細胞内シグナル伝達阻害薬が内分泌療法耐性乳癌の治療感受性を回復させる機序の解明
  • 2014 - 2017 Elucidation of the interaction between crosstalk between ER and HER2 and drug resistance mechanism in breast cancer
  • 2011 - 2016 Regulation of cell dynamism by phosphoinositides
  • 2013 - 2016 Basic Research for Carbon-Ion Radiotherapy for Breast Cancer
Papers (63)：
  • Yutaka Natori, Junko Suga, Emi Tokuda, Kazunoshin Tachibana, Jun-ichi Imai, Reiko Honma, Yusuke Azami, Masaru Noda, Eisaku Sasaki, Shinya Watanabe, et al. E3 Ubiquitin Ligase NEDD4 Affects Estrogen Receptor α Expression and the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer. Cancers. 2023. 15. 2. 539-539
  • Morita M, Shimomura A, Tokuda E, Horimoto Y, Kawamura Y, Ishizuka Y, Sekine K, Obayashi S, Kojima Y, Uemura Y, et al. Is adjuvant chemotherapy necessary in older patients with breast cancer?( Online ahead of print.). Breast Cancer. 2022
  • 竹村 真生子, 岡崎 護, 羽成 直行, 徳田 恵美, 田辺 真彦, 林 嗣博, 水谷 知央, 林 孝朗, 中村 優飛, 根本 悠里, et al. Everolimus+Exemestane療法後に腫瘍崩壊症候群をきたした進行乳癌の一例. 福島医学雑誌. 2021. 71. 1. 35-40
  • Natori Y, Sasaki E, Soeda S, Furukawa S, Azami Y, Tokuda E, Kanbayashi T, Saji S. Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab. Journal for immunotherapy of cancer. 2020. 8. 2. e001164-e001164
  • Iida Masafumi, Toyosawa Daichi, Nakamura Misato, Tsuboi Kouki, Tokuda Emi, Niwa Toshifumi, Ishida Takanori, Hayashi Shin-ichi. Decreased ER dependency after acquired resistance to CDK4/6 inhibitors(CDK4/6阻害薬に対する耐性獲得後のER依存性低下). Breast Cancer. 2020. 27. 5. 963-972
ｍore...
MISC (48)：
ｍore...
Lectures and oral presentations  (17)：
  • Ubiquitin ligase NEDD4 promotes degradation of estrogen receptor in breast cancer and affects prognosis.
    (第19回日本臨床腫瘍学会学術集会(JSMO2022) 2022)
  • Current status and research issues of late recurrence in breast cancer treatment.
    (第80回日本癌学会学術総会 2021)
  • ER発現が低下した内分泌療法耐性乳癌細胞のER発現をPI3K阻害薬が再発現させる機序にエピゲノム変化が関与する
    (第29回日本乳癌学会総会 2021)
  • 妊娠中に周術期化学療法を行った乳癌患者への多職種連携支援の重要性
    (第18回日本臨床腫瘍学会学術集会(JSMO2021) 2021)
  • 免疫チェックポイント阻害薬によるナルコレプシー発症のリスク
    (第18回日本臨床腫瘍学会学術集会(JSMO2021) 2021)
ｍore...
Association Membership(s) (6)：
JAPAN SURGICAL SOCIETY ,  日本乳癌学会 ,  JAPAN SURGICAL ASSOCIATION ,  オンコプラスティックサージェリー学会 ,  日本乳癌検診学会 ,  日本臨床腫瘍学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM